New Step by Step Map For ITD-1
Kantarjian et al53 assessed the efficacy and safety of dasatinib, as compared with imatinib, for the first-line cure of CML-CP. Five hundred and nineteen people with recently diagnosed CML-CP were randomly assigned to obtain dasatinib at a dose of one hundred mg once day-to-day (259 patients) or ima